T. Rowe Price Associates
EUCRU

T. Rowe Price Associates’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

T. Rowe Price Associates’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
2021
Q4 		$7.29M Hold
2021
Q3 		$7.28M Hold
2021
Q2 		$7.45M Sell
2021
Q1 		$7.94M Buy
2020
Q4 		$8.17M Buy